Details for New Drug Application (NDA): 075325
✉ Email this page to a colleague
NDA 075325 describes EMBELINE E, which is a drug marketed by Hikma and is included in one NDA. Additional details are available on the EMBELINE E profile page.
The generic ingredient in EMBELINE E is clobetasol propionate. There are fourteen drug master file entries for this compound. Forty suppliers are listed for this compound. Additional details are available on the clobetasol propionate profile page.
The generic ingredient in EMBELINE E is clobetasol propionate. There are fourteen drug master file entries for this compound. Forty suppliers are listed for this compound. Additional details are available on the clobetasol propionate profile page.
Summary for 075325
| Tradename: | EMBELINE E |
| Applicant: | Hikma |
| Ingredient: | clobetasol propionate |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 075325
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CREAM;TOPICAL | Strength | 0.05% | ||||
| Approval Date: | Dec 24, 1998 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
